Monopar Therapeutics Inc. · NASDAQ:MNPR

Janus Henderson Group PLC reported a 17.20% stake in Monopar Therapeutics Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Jan 8, 2025

Janus Henderson Group PLC reported a 17.20% stake in Monopar Therapeutics Inc., 1,046,899 shares, as a passive investor on Dec 31, 2024. Filed Jan 8, 2025 (Schedule 13G/A).

Stake
17.20%
Shares
1,046,899
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
JANUS HENDERSON GROUP PLC17.20%1,046,899
Janus Henderson Biotech Innovation Master Fund Ltd15.60%952,829

Source

View original at SEC

Related